ABVC BioPharma, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ABVC BioPharma, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- ABVC BioPharma, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $411.67K, a 39.55% decline year-over-year.
- ABVC BioPharma, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $737.50K.
- ABVC BioPharma, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $681.00K.
- ABVC BioPharma, Inc. stock issued during period, value, stock options exercised for fiscal 2015 was $0.00.
- ABVC BioPharma, Inc. stock issued during period, value, stock options exercised for fiscal 2014 was $0.00.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | |
| 2025-03-31 | $411.67K 10-Q · filed 2025-04-30 | |
| 2024-06-30 | $737.50K 10-Q · filed 2025-08-13 | |
| 2024-03-31 | $681.00K 10-Q · filed 2024-05-17 | |
| 2023-09-30 | -$699.80K 10-Q · filed 2023-11-15 | |
| 2015-09-30 | $0.00 10-K · filed 2015-11-27 | |
| 2014-09-30 | $0.00 10-K · filed 2015-11-27 |